comparemela.com

Latest Breaking News On - Pyxis oncology - Page 9 : comparemela.com

Individual investors among Pyxis Oncology, Inc s (NASDAQ:PYXS) largest shareholders, saw gain in holdings value after stock jumped 18% last week

Key Insights Pyxis Oncology's significant individual investors ownership suggests that the key decisions are influenced.

Klara sullivanPfizer incPyxis oncology incPublic company ownershipPyxis oncologyInstitutional investorsNdividual investorsNstitutional ownershipOwnership structure

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPamela connealyKen kobayashiPyxis oncology incPyxis oncologyCompensation committeeChief medical officerNasdaq listing rule

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesKen kobayashiPamela connealyPyxis oncology incPyxis oncologyCompensation committeeChief medical officerNasdaq listing rule

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Dec. 29, 2023 Pyxis Oncology, Inc. , a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis.

United statesPamela connealyKen kobayashiPyxis oncology incPyxis oncologyCompensation committeeChief medical officerNasdaq listing rule

Head to Head Contrast: Pyxis Oncology (NASDAQ:PYXS) & CytoDyn (OTCMKTS:CYDY)

Pyxis Oncology (NASDAQ:PYXS – Get Free Report) and CytoDyn (OTCMKTS:CYDY – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Profitability This table compares Pyxis Oncology and CytoDyn’s […]

United statesUnited kingdomBritish columbiaPyxis oncology incRexray corporationCytodyn incPyxis oncologyGet free reportGiven pyxis oncologyDyn incPyxis oncology dailyNasdaq pyxsStock comparisonStock analysis

vimarsana © 2020. All Rights Reserved.